Aqtual
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31145 San Antonio St, Hayward, Californi...Phone Number
(341) 208-8569Website
www.aqtual.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aqtual
Aqtual, Inc. is a precision medicine company developing products for chronic disease management and oncology utilizing a novel cell-free DNA-based platform. Aqtuals proprietary platform evaluates protein regulation, epigenetics, and transcriptomics solely using cell-free DNA fragments found in the blood. The platform yields efficient and robust real-time analysis of disease and treatment while overcoming the limitations of previous cell-free DNA methodologies.Explore more
Aqtual Org Chart
Get the full picture
Sign in to uncover key details.
RC
Associate Director, Research & Development
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aqtual your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Aqtual
Check if Aqtual has recently received funding, and reach out quickly before it becomes old news!
Click to see if Aqtual had a recent Job posting/layoffs
Earning: See what the market has to say on Aqtual recently announced quarterly report
Check out if Aqtual is spiking on competitors!
Product Launch: Get notified when Aqtual launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aqtual has new funding data
Aqtual, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Aqtual as Masked Content
Find 3 more new buyers
Compare Similar Companies to Aqtual
Compare insights from companies similar to Aqtual, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aqtual is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aqtual is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aqtual.
Aqtual financials insights
Gather financial insights about Aqtual, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$16M
2025
Series B
$31M
Aqtual Tech Stack
Most Recent Scoops
Funding
Funding
Executive Move
Board of Directors
Funding
Funding
Aqtual News & Media
Aqtual Presents New Data on Development of RA Therapy Selection Test at ACR Convergence 2024
HAYWARD, Calif.--(BUSINESS WIRE)--Aqtual, Inc., a precision medicine company using its novel active chromatin cell-free DNA platform to develop products for chronic diseases and oncology, today announced the presentation of new data supporting its innovative blood-based test for rheumatoid arthritis (RA) therapy selection. Presented at the American College of Rheumatology (ACR) Convergence 2024, the data highlights significant clinical trial progress and reinforces the company's plans to commerAqtual Research Demonstrates Applications of Novel Cell-Free DNA Approach in Precision Medicine
HAYWARD, Calif.--(BUSINESS WIRE)--Aqtual, Inc., a precision medicine company with a novel active chromatin cell-free DNA (cfDNAac) platform to develop products for chronic diseases and oncology, announced research in Communications Biology, a Nature portfolio journal. The research demonstrates the potential of Aqtual’s proprietary platform that evaluates gene regulation, epigenetics, and transcriptomics by analyzing previously unexplored cfDNA fragments found in blood, opening the door to new cAqtual to Present Data on Innovative Approach to Rheumatoid Arthritis Therapy Selection at CCR East 2024
HAYWARD, Calif., May 9, 2024 /PRNewswire/ -- Aqtual, Inc., a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology, today announced it is presenting two posters at the Congress of Clinical Rheumatology 2024 meeting in...Aqtual to Present Poster at American Association for Cancer Research Annual Meeting 2024
Study highlights the potential for active chromatin cell-free DNA analysis to impact applications across precision oncology HAYWARD, Calif., March 27, 2024 /PRNewswire/ -- Aqtual, Inc., a precision medicine company using its novel cell-free DNA platform to develop products for chronic...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Aqtual
Sign Up For FreeTo access detailed company insights
Aqtual, Inc. is a precision medicine company developing products for chronic disease management and oncology utilizing a novel cell-free DNA-based platform. Aqtuals proprietary platform evaluates protein regulation, epigenetics, and transcriptomics solely using cell-free DNA fragments found in the blood. The platform yields efficient and robust rea... Read More
